Stable Dried Catalase Particles Prepared by Electrospraying
Source abstract
Abstract
Therapeutic proteins and peptides are clinically important, offering potency while reducing the potential for off-target effects. Research interest in developing therapeutic polypeptides has grown significantly during the last four decades. However, despite the growing research effort, maintaining the stability of polypeptides throughout their life cycle remains a challenge. Electrohydrodynamic (EHD) techniques have been widely explored for encapsulation and delivery of many biopharmaceuticals. In this work, we explored monoaxial electrospraying for encapsulation of bovine liver catalase, investigating the effects of the different components of the electrospraying solution on the integrity and bioactivity of the enzyme. The catalase was successfully encapsulated within polymeric particles made of polyvinylpyrrolidone (PVP), dextran, and polysucrose. The polysorbate 20 content within the electrospraying solution (50 mM citrate buffer, pH 5.4) affected the catalase loading—increasing the polysorbate 20 concentration to 500 μg/mL resulted in full protein encapsulation but did not prevent loss in activity. The addition of ethanol (20% v/v) to a fully aqueous solution improves the electrospraying process by reducing surface tension, without loss of catalase activity. The polymer type was shown to have the greatest impact on preserving catalase activity within the electrosprayed particles. When PVP was the carrier there was no loss in activity compared with fresh aqueous solutions of catalase. The optimum particles were obtained from a 20% w/v PVP or 30% w/v PVP-trehalose (1:1 w/w) solution. The addition of trehalose confers stability advantages to the catalase particles. When trehalose-PVP particles were stored at 5 °C, enzymatic activity was maintained over 3 months, whereas for the PVP-only analogue a 50% reduction in activity was seen. This demonstrates that processing catalase by monoaxial electrospraying can, under optimised conditions, result in stable polymeric particles with no loss of activity.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrohydrodynamics and Fluid Dynamics · Enzyme Catalysis and Immobilization · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK
Funding
the UK Engineering and Physical Sciences Research Council (EPSRC)
References (53)
Show source-provided references
1. Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery10.1016/j.csbj.2019.09.004 ↗
2. Protein therapeutics: A summary and pharmacological classification10.1038/nrd2399 ↗
3. Protein encapsulation by electrospinning and electrospraying10.1016/j.jconrel.2020.10.046 ↗
4. Challenges in liquid chromatographic characterization of proteins10.1016/j.jchromb.2016.04.037 ↗
5. Crommelin, D.J.A., Sindelar, R.D., and Meibohm, B. (2019). Pharmaceutical Biotechnology: Fundamentals and Applications, Springer International Publishing. [5th ed.].10.1007/978-3-030-00710-2 ↗
6. Pharmaceutical Applications of Electrospraying10.1016/j.xphs.2016.04.024 ↗
7. Spray Drying of Biopharmaceuticals: Stability and Process Considerations10.1080/03602550600685275 ↗
8. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain10.1073/pnas.1206210109 ↗
9. Protein drug delivery: Current dosage form profile and formulation strategies10.1080/1061186X.2019.1669043 ↗
10. Encapsulation of proteins in poly(l-lactide-co-caprolactone) fibers by emulsion electrospinning10.1016/j.colsurfb.2009.09.014 ↗
11. Examining the formulation of emulsion electrospinning for improving the release of bioactive proteins from electrospun fibers: Formulation of Emulsion Electrospinning10.1002/jbm.a.34730 ↗
12. A controlled release system of superoxide dismutase by electrospun fiber and its antioxidant activity in vitro10.1007/s10856-009-3927-6 ↗
13. Production of protein nanoparticles by electrospray drying10.1016/S0021-8502(97)10031-3 ↗
14. Monoclonal antibody formulation manufactured by high-speed electrospinning10.1016/j.ijpharm.2020.120042 ↗
15. Electrospun formulations of bevacizumab for sustained release in the eye10.1016/j.actbio.2017.10.015 ↗
16. Lee, D.-S., Kang, D.W., Choi, G.-W., Choi, H.-G., and Cho, H.-Y. (2020). Development of Level A In Vitro–Vivo Correlation for Electrosprayed Microspheres Containing Leuprolide: Physicochemical, Pharmacokinetic, and Pharmacodynamic Evaluation. Pharmaceutics, 12.10.3390/pharmaceutics12010036 ↗
17. Chitosan nanofibers for transbuccal insulin delivery10.1002/jbm.a.35984 ↗
18. Williams, G.R., Raimi-Abraham, B.T., and Luo, C.J. (2018). Nanofibres in Drug Delivery, UCL Press. [1st ed.].10.2307/j.ctv550dd1 ↗
19. Feasibility of electrospraying fully aqueous bovine serum albumin solutions10.1016/j.ejpb.2019.12.011 ↗
20. An investigation of alkaline phosphatase enzymatic activity after electrospinning and electrospraying10.1016/j.jddst.2021.102592 ↗
21. Focarete, M.L., and Tampieri, A. (2018). Core-Shell Nanostructures for Drug Delivery and Theranostics: Challenges, Strategies, and Prospects for Novel Carrier Systems, Woodhead Publishing. [1st ed.].10.1016/B978-0-08-102198-9.00001-6 ↗
22. Evolution of Catalases from Bacteria to Humans10.1089/ars.2008.2046 ↗
23. Unique oligomeric intermediates of bovine liver catalase10.1110/ps.20102 ↗
24. Development of novel delivery system for nanoencapsulation of catalase: Formulation, characterization, and in vivo evaluation using oxidative skin injury model10.1080/21691401.2018.1425213 ↗
25. Controlled Elimination of Intracellular H2O2: Regulation of Peroxiredoxin, Catalase, and Glutathione Peroxidase via Post-translational Modification10.1089/ars.2005.7.619 ↗
26. Photodynamic therapy10.1016/j.mla.2005.02.001 ↗
27. A simple route to functionalising electrospun polymer scaffolds with surface biomolecules10.1016/j.ijpharm.2021.120231 ↗
28. Effect of ionic strength on the heat-induced soy protein aggregation and the phase separation of soy protein aggregate/dextran mixtures10.1016/j.foodhyd.2008.07.024 ↗
29. Protein stability modulated by a conformational effector: Effects of trifluoroethanol on bovine serum albumin10.1039/b818687a ↗
30. On the Structural Stability and Solvent Denaturation of Proteins10.1016/S0021-9258(18)63111-4 ↗
31. Effect of heat, pH, ultrasonication and ethanol on the denaturation of whey protein isolate using a newly developed approach in the analysis of difference-UV spectra10.1016/j.foodchem.2017.04.022 ↗
32. Surfactant-aided electrospraying of low molecular weight carbohydrate polymers from aqueous solutions10.1016/j.carbpol.2013.09.032 ↗
33. The formulation of biopharmaceutical products10.1016/S1461-5347(00)00248-0 ↗
34. Carpenter, J.F., and Manning, M.C. (2002). Rational Design of Stable Protein Formulation, Springer. Pharmaceutical Biotechnology.10.1007/978-1-4615-0557-0 ↗
35. Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development10.1016/j.addr.2011.07.006 ↗
36. Factors affecting the physical stability (aggregation) of peptide therapeutics10.1098/rsfs.2017.0030 ↗
37. Dextran: Sources, Structures, and Properties10.3390/polysaccharides2030033 ↗
38. Determination of CMC of Polysorbate 20 in Aqueous Solution by Surface Tension Method10.1002/jps.2600610842 ↗
39. Comparison of the effects of 2,2,2-trifluoroethanol on peptide and protein structure and function10.1016/j.jsb.2006.07.008 ↗
40. Effect of shear viscosity on the preparation of sphere-like silk fibroin microparticles by electrospraying10.1016/j.ijbiomac.2015.05.040 ↗
41. Electrospraying, a Reproducible Method for Production of Polymeric Microspheres for Biomedical Applications10.3390/polym3010131 ↗
42. Preparation and characterization of solid dispersions of carvedilol with PVP K30
43. Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy10.1038/nprot.2015.024 ↗
44. FTIR spectroscopic characterization of protein structure in aqueous and non-aqueous media10.1016/S1381-1177(99)00030-2 ↗
45. Characterization of the Phase Transitions of Trehalose Dihydrate on Heating and Subsequent Dehydration10.1021/js970239m ↗
46. Electrospun nanofibers in drug delivery: Recent developments and perspectives10.4155/tde.12.17 ↗
47. Pharmaceutical protein solids: Drying technology, solid-state characterization and stability10.1016/j.addr.2021.02.016 ↗
48. In pursuit of functional electrospun materials for clinical applications in humans10.4155/tde-2016-0017 ↗
49. Stabilization of proteins in solid form10.1016/j.addr.2015.05.006 ↗
50. Effects of Excipients on Protein Conformation in Lyophilized Solids by Hydrogen/Deuterium Exchange Mass Spectrometry10.1007/s11095-007-9365-6 ↗
51. Influence of Miscibility of Protein-Sugar Lyophilizates on Their Storage Stability10.1208/s12248-016-9937-7 ↗
52. Storage stability of keratinocyte growth factor-2 in lyophilized formulations: Effects of formulation physical properties and protein fraction at the solid–air interface10.1016/j.ejpb.2014.05.012 ↗
53. Protein Quantification by Bicinchoninic Acid (BCA) Assay Follows Complex Kinetics and Can Be Performed at Short Incubation Times10.1016/j.ab.2020.113904 ↗